SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
MGI Pharma MOGN New patents, anti cancer
An SI Board Since June 1996
Posts SubjectMarks Bans Symbol
1826 45 0 MOGN
Emcee:  Mark Oliver Type:  Unmoderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
1626That would have been nice, but come, now: the abstracts have been available for tuck-12/12/2005
1625I half expected a bit of a pop today on the MYOG news <g>. It's been FiloF-12/12/2005
1624I just listened myself. The only thing I can think of that might have scared petuck-12/8/2005
1623>>Did they confirm my suspicion that Dacogen will get a Class II review? IIcebrg-12/8/2005
1622According to a YMB poster, MGI confirmed '05 guidance, suggesting Zhang is atuck-12/8/2005
1621MGI Pharma (nasdaq: MOGN - news - people ) fell 8.7% for the week after monthly John McCarthy-12/5/2005
1620MGI Pharma Seen Meeting 2005 Guidance For Aloxi Peter Kang, 11.29.05, 4:07 PM ETIcebrg-11/29/2005
1619BiotechStockBlogger suspects that because Dacogen clinical data is involved in ttuck-11/16/2005
1618MOGN/SUPG replies to Dacogen approvable letter: >>MINNEAPOLIS & DUBLItuck-11/15/2005
1617Clinical experience with decitabine in North American patients with myelodysplasIcebrg-11/8/2005
1616A phase II study of irofulven in women with recurrent and heavily pretreated ovaIcebrg-11/3/2005
1615>>have they mentioned that they are looking for a European partner?>>Icebrg-10/26/2005
1614What I have seen is what I am sure you already know and what another YMB poster FiloF-10/26/2005
1613Thanks, so have they mentioned that they are looking for a European partner? &gtuck-10/26/2005
1612Tuck, Sorry, I have no idea whatsoever. Generally speaking Europe should be a vIcebrg-10/26/2005
1611Erik, A YMB poster thinks the sell-off is an overreaction because Supergen getstuck-10/26/2005
1610Fears of EMEA wanting more Dacogen data have sent MOGN down 4.5%. CVTX had to wtuck-10/26/2005
1609I don't remember whether I posted this snippet from yesterday's Merrill tom pope-10/21/2005
1608MGI PHARMA shares drop more than 10 pct. OCT. 20 2:26 P.M. ET Shares of drug makIcebrg-10/21/2005
1607Revenue slightly light, earnings a penny light. >>MINNEAPOLIS--(BUSINESS tuck-10/19/2005
1606Lannett Gets FDA OK for Generic Salagen Associated Press 10.17.2005, 10:36 AM LIcebrg-10/17/2005
1605From Merrill  Company Update; Aquavan Data Could Provide Long-Term Growth Visitom pope-10/17/2005
1604Nice deal.tom pope-10/5/2005
1603It seems as if Dean Mitchell ex-CEO of Guilford was very motivated, eager and haIcebrg-10/5/2005
1602MGI Pharma "outperform," target price reduced Wednesday, October 05, Icebrg-10/5/2005
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News